TY  - BOOK
AU  - Schweizer,Lars
AU  - Dingermann,Theodor
AU  - Russe,Otto Quintus
AU  - Jansen,Christian
ED  - SpringerLink (Online service)
TI  - Advances in Pharma Business Management and Research: Volume 1 
SN  - 9783030359188
AV  - RS380 
U1  - 615.19 23
PY  - 2020///
CY  - Cham
PB  - Springer International Publishing, Imprint: Springer
KW  - Pharmaceutical technology
KW  - Health care management
KW  - Health services administration
KW  - Medical laws and legislation
KW  - Pharmacy
KW  - Pharmacy management
KW  - Pharmaceutical Sciences/Technology
KW  - Health Care Management
KW  - Medical Law
KW  - Pharmacoeconomics and Health Outcomes
N1  - Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management; Open Access
N2  - This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business
UR  - https://doi.org/10.1007/978-3-030-35918-8
ER  -